BRPI0705319A2 - processo para obtenção de um complexo solúvel de resveratrol e/ou seus derivados; complexo de resveratrol e/ou seus derivados; composição nutracêutica - Google Patents
processo para obtenção de um complexo solúvel de resveratrol e/ou seus derivados; complexo de resveratrol e/ou seus derivados; composição nutracêuticaInfo
- Publication number
- BRPI0705319A2 BRPI0705319A2 BRPI0705319-3A BRPI0705319A BRPI0705319A2 BR PI0705319 A2 BRPI0705319 A2 BR PI0705319A2 BR PI0705319 A BRPI0705319 A BR PI0705319A BR PI0705319 A2 BRPI0705319 A2 BR PI0705319A2
- Authority
- BR
- Brazil
- Prior art keywords
- derivatives
- resveratrol
- obtaining
- resveratrol complex
- nutraceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof
Abstract
Processo para obtenção de um complexo solúvel de resveratrol e/ou seus derivados; Complexo de resveratrol e/ou seus derivados; Composição nutracêutica. A presente invenção proporciona produtos contendo resveratróis melhorados e composições nutracêuticas e/ou fitoterápicas contendo as referidas substâncias Os processos para sua obtenção envolvem o aumento da solubilidade do polifenol trans-resveratrol e/ou seus derivados em água, através de sua complexação com ciclodextrina. Os produtos da invenção apresentam elevada solubilidade em meio aquoso e elevado grau de pureza, sendo, portanto, úteis na preparação de composições nutracêuticas (farmacêuticas e/ou alimetícias) com ação antioxidante, antiinflamatória, antiviral, cardioprotetora, neuroprotetora e/ou quimiopreventiva de câncer, além de proteger contra infecções e isquemia, reduzir a obesidade e prevenir o envelhecimento. São também proporcionados fitoterápicos úteis para as mesmas ações terapêuticas, preparados a partir do uso do complexo beta-ciclodextrina/trans-resveratrol; e um intermediário de síntese útil na derivatização química para a obtenção de ingredientes ativos melhorados.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0705319-3A BRPI0705319A2 (pt) | 2007-07-23 | 2007-07-23 | processo para obtenção de um complexo solúvel de resveratrol e/ou seus derivados; complexo de resveratrol e/ou seus derivados; composição nutracêutica |
PCT/BR2008/000216 WO2009012551A1 (en) | 2007-07-23 | 2008-07-23 | Resveratrol complex and process for the preperation |
BRPI0814308A BRPI0814308B8 (pt) | 2007-07-23 | 2008-07-23 | processo de preparo, complexo compreendendo resveratrol e ciclodextrina, composições e uso |
US12/670,310 US8476248B2 (en) | 2007-07-23 | 2008-07-23 | Process for the preparation of a water-soluble complex having resveratrol compounds; products comprising said complex; and uses thereof |
EP08772766.5A EP2178525A4 (en) | 2007-07-23 | 2008-07-23 | RESVERATROL COMPLEX AND METHOD OF MANUFACTURE |
CA2694343A CA2694343C (en) | 2007-07-23 | 2008-07-23 | Resveratrol complex and process for the preperation |
EC2010009982A ECSP109982A (es) | 2007-07-23 | 2010-02-22 | Proceso de preparación del complejo soluble en agua conteniendo el compuesto resveratrol, productos formando dicho complejo y usos de los mismos |
CO10021163A CO6260022A2 (es) | 2007-07-23 | 2010-02-23 | Proceso de preparacion de complejo soluble en agua conteniendo el compuesto resveratrol productos formando dicho complejo y usos del mismos |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0705319-3A BRPI0705319A2 (pt) | 2007-07-23 | 2007-07-23 | processo para obtenção de um complexo solúvel de resveratrol e/ou seus derivados; complexo de resveratrol e/ou seus derivados; composição nutracêutica |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0705319A2 true BRPI0705319A2 (pt) | 2009-07-21 |
Family
ID=40280935
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0705319-3A BRPI0705319A2 (pt) | 2007-07-23 | 2007-07-23 | processo para obtenção de um complexo solúvel de resveratrol e/ou seus derivados; complexo de resveratrol e/ou seus derivados; composição nutracêutica |
BRPI0814308A BRPI0814308B8 (pt) | 2007-07-23 | 2008-07-23 | processo de preparo, complexo compreendendo resveratrol e ciclodextrina, composições e uso |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0814308A BRPI0814308B8 (pt) | 2007-07-23 | 2008-07-23 | processo de preparo, complexo compreendendo resveratrol e ciclodextrina, composições e uso |
Country Status (7)
Country | Link |
---|---|
US (1) | US8476248B2 (pt) |
EP (1) | EP2178525A4 (pt) |
BR (2) | BRPI0705319A2 (pt) |
CA (1) | CA2694343C (pt) |
CO (1) | CO6260022A2 (pt) |
EC (1) | ECSP109982A (pt) |
WO (1) | WO2009012551A1 (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2593576C (en) | 2004-01-20 | 2013-04-23 | Brigham Young University | Novel sirtuin activating compounds and methods for making the same |
BRPI0806044A2 (pt) * | 2008-10-17 | 2010-09-14 | Ubea | método e kit para determinação de agentes moduladores de sirtuìnas, processo para modulação de sirtuìnas, compostos moduladores de sirtuìnas e composições compreendendo os mesmos |
WO2010058242A1 (en) * | 2008-11-24 | 2010-05-27 | Giovanni Nicolao Berta | New formulations with anti-neoplastic activity |
BRPI0900400B1 (pt) * | 2009-02-10 | 2017-12-19 | União Brasileira De Educação E Assistência | Composition understanding vegetable oil and resveratrol and process for producing them |
WO2010102245A1 (en) * | 2009-03-05 | 2010-09-10 | Upsher-Smith Laboratories, Inc. | Solid dispersion comprising resveratrol |
ES2798254T3 (es) | 2009-06-22 | 2020-12-10 | Indus Biotech Private Ltd | Proceso para la obtención de pteroestilbeno purificado y métodos de uso del mismo |
RU2464042C1 (ru) * | 2011-03-31 | 2012-10-20 | Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" | КЛАТРАТНЫЙ КОМПЛЕКС β-ЦИКЛОДЕКСТРИНА С ПРОИЗВОДНЫМ 5-ГИДРОКСИ-4-АМИНОМЕТИЛ-1-ЦИКЛОГЕКСИЛ(ИЛИ ЦИКЛОГЕПТИЛ)-3-АЛКОКСИКАРБОНИЛИНДОЛА, СПОСОБ ЕГО ПОЛУЧЕНИЯ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО |
CN103120310A (zh) * | 2011-11-20 | 2013-05-29 | 重庆还少堂生物技术有限责任公司 | 白藜芦醇水溶性干粉的制配方法 |
CN103356476B (zh) * | 2012-03-31 | 2016-02-17 | 昆药集团股份有限公司 | 溶解黄酮类化合物、碳苷类化合物或茋类化合物的方法及注射液或注射用粉针剂的制备方法 |
ITRM20120275A1 (it) * | 2012-06-13 | 2013-12-14 | Noos S R L | Associazione di resveratrolo e carbossimetilglucano. |
KR101480600B1 (ko) * | 2013-01-22 | 2015-01-08 | 경북대학교 산학협력단 | 레스베라트롤 유도체의 피부미백 용도 |
RU2594281C2 (ru) * | 2013-04-03 | 2016-08-10 | Чайна Медикал Юнивёсити | Стильбеноидные соединения в качестве ингибиторов плоскоклеточной карциномы и гепатомы и их применения |
WO2015027068A1 (en) * | 2013-08-21 | 2015-02-26 | Concordia University | Dendrimer-resveratrol complex |
JP6435158B2 (ja) * | 2014-10-17 | 2018-12-05 | 森永製菓株式会社 | 精製スチルベン化合物の製造方法 |
US20180085392A1 (en) * | 2015-04-17 | 2018-03-29 | Sens Research Foundation, Inc. | Cyclodextrin compounds for the prevention and treatment of aging |
CN110325217B (zh) * | 2017-01-09 | 2023-08-08 | 塞法姆公司 | 制备水溶性毛喉萜的新工艺 |
CN108774290B (zh) * | 2018-07-10 | 2020-09-04 | 宁夏蓝博思化学技术有限公司 | 白藜芦醇-羧烷基型环糊精衍生物及其制备方法 |
WO2020023807A1 (en) * | 2018-07-26 | 2020-01-30 | The Regents Of The University Of California | Treatment of vascular occlusion by activation of notch signaling |
EP3603415B1 (fr) * | 2018-07-30 | 2020-12-30 | Universite D'Avignon et Des Pays Du Vaucluse | Procede d'extraction de composes phenoliques |
US10882012B2 (en) * | 2018-08-03 | 2021-01-05 | Wakamono Corporation | Process for producing a nano resveratrol microemulsion system |
TWI689304B (zh) * | 2018-12-04 | 2020-04-01 | 高雄醫學大學 | 抗霧霾組合物 |
CN111001013B (zh) * | 2019-12-12 | 2023-04-18 | 安徽工业大学 | 一种枇杷叶提取物纳米胶囊、制备方法及应用 |
CN111387393B (zh) * | 2020-05-07 | 2022-09-20 | 北京维泰力特生物医药有限公司 | 一种含有小分子肽、白藜芦醇和花青素的饮料及其制备方法 |
CN114656645B (zh) * | 2022-03-23 | 2023-02-24 | 齐鲁工业大学 | 一种在水相中稳定存在的环糊精金属有机框架的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6884885B2 (en) * | 2000-12-21 | 2005-04-26 | Cerestar Holding B.V. | Production of cyclodextrin complexes |
US20060292099A1 (en) * | 2005-05-25 | 2006-12-28 | Michael Milburn | Treatment of eye disorders with sirtuin modulators |
WO2006138418A2 (en) * | 2005-06-14 | 2006-12-28 | President And Fellows Of Harvard College | Improvement of cognitive performance with sirtuin activators |
-
2007
- 2007-07-23 BR BRPI0705319-3A patent/BRPI0705319A2/pt not_active Application Discontinuation
-
2008
- 2008-07-23 US US12/670,310 patent/US8476248B2/en not_active Expired - Fee Related
- 2008-07-23 BR BRPI0814308A patent/BRPI0814308B8/pt active IP Right Grant
- 2008-07-23 WO PCT/BR2008/000216 patent/WO2009012551A1/en active Application Filing
- 2008-07-23 EP EP08772766.5A patent/EP2178525A4/en not_active Withdrawn
- 2008-07-23 CA CA2694343A patent/CA2694343C/en not_active Expired - Fee Related
-
2010
- 2010-02-22 EC EC2010009982A patent/ECSP109982A/es unknown
- 2010-02-23 CO CO10021163A patent/CO6260022A2/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2694343C (en) | 2016-03-29 |
WO2009012551A4 (en) | 2009-03-12 |
WO2009012551A1 (en) | 2009-01-29 |
BRPI0814308A2 (pt) | 2015-02-03 |
US8476248B2 (en) | 2013-07-02 |
BRPI0814308B1 (pt) | 2020-10-27 |
EP2178525A4 (en) | 2013-08-28 |
CO6260022A2 (es) | 2011-03-22 |
BRPI0814308B8 (pt) | 2021-05-25 |
EP2178525A1 (en) | 2010-04-28 |
ECSP109982A (es) | 2010-04-30 |
CA2694343A1 (en) | 2009-01-29 |
US20100204179A1 (en) | 2010-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0705319A2 (pt) | processo para obtenção de um complexo solúvel de resveratrol e/ou seus derivados; complexo de resveratrol e/ou seus derivados; composição nutracêutica | |
Nguyen et al. | Facile preparation of water soluble curcuminoids extracted from turmeric (Curcuma longa L.) powder by using steviol glucosides | |
De Bruyne et al. | Biological evaluation of proanthocyanidin dimers and related polyphenols | |
Duan et al. | Comprehensive evaluation of deep eutectic solvents in extraction of bioactive natural products | |
Nguyen et al. | An investigation into the supramolecular structure, solubility, stability and antioxidant activity of rutin/cyclodextrin inclusion complex | |
BRPI0508879A (pt) | transferência de ingredientes funcionais | |
WO2009032773A3 (en) | Compositions and methods for treating demodex infestations | |
MX2013013734A (es) | Familia de carba-azucares de arilo, heteroarilo, o-arilo y o-heteroarilo. | |
BR112016007069B8 (pt) | Processo para produção de uma composição de glicosil estévia, composição de glicosil estévia, ingrediente alimentício, produto alimentício, de bebida, cosmético ou farmacêutico | |
CL2008001839A1 (es) | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. | |
CL2012001336A1 (es) | Composicion farmaceutica solida de daptomicina preparada por liofilizacion de una solucion acuosa que comprende daptomicina y al menos un excipiente seleccionado de glicina y un azucar no reductor con un ph de 6,5-7,5; producto farmaceutico; metodo de fabricacion; uso para tratar infecciones bacterianas. | |
BRPI0612957B8 (pt) | composto, processos de preparação de compostos, composição farmacêutica e uso de um composto | |
Zhang et al. | Aqueous solubility and stability enhancement of astilbin through complexation with cyclodextrins | |
BR112013010958A8 (pt) | Métodos para elevar a solubilidade de compostos pouco solúveis e métodos para fabricação e para uso de formulações de tais compostos | |
BRPI0809330B8 (pt) | uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica | |
WO2007121352A3 (en) | Therapeutic triterpenoids | |
WO2010012904A3 (fr) | Nouveaux dérivés de l'oxime de cholest-4-èn-3-one, compositions pharmaceutiques les renfermant, et procédé de préparation | |
Luo et al. | Maillard reaction products from chitosan–xylan ionic liquid solution | |
UY30215A1 (es) | Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones | |
ATE485261T1 (de) | Salicylsäurederivate | |
WO2008009831A3 (fr) | Derives de cyclodextrines amphiphiles | |
BR112015026441A2 (pt) | derivados de fulereno aperfeiçoados e materiais, métodos e dispositivos relacionados | |
BR112014009623A2 (pt) | composição de glicosil stevia | |
AR063467A1 (es) | Preparacion de sales farmaceuticas del acido 3-o-(3',3'-dimetilsuccinil)betulinico; sales del mismo, composiciones farmaceuticas que las comprenden y el empleo de estas en el tratamiento de infecciones con vih. | |
BR112012026714A2 (pt) | pastilhas de eritritol e isomalte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO EM SUA FORMA AUTENTICADA; OU SEGUNDO O PARECER DA PROCURADORIA NO 074/93, DEVE CONSTAR UMA DECLARACAO DE VERACIDADE, A QUAL DEVE SER ASSINADA POR UMA PESSOA DEVIDAMENTE AUTORIZADA A REPRESENTAR O INTERESSADO, DEVENDO A MESMA CONSTAR NO INSTRUMENTO DE PROCURACAO, OU NO SEU SUBSTABELECIMENTO. |
|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |